SCM
Sterling Capital Management Portfolio holdings
AUM
$7.04B
1-Year Return
20.28%
This Quarter Return
+3.31%
1 Year Return
+20.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$11.2B
AUM Growth
-$290M
(-2.5%)
Cap. Flow
-$595M
Cap. Flow
% of AUM
-5.32%
Top 10 Holdings %
Top 10 Hldgs %
21.94%
Holding
1,051
New
144
Increased
300
Reduced
354
Closed
185
Top Buys
| 1 |
Wells Fargo
WFC
|
+$125M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$105M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$64.6M |
| 4 |
IBM
IBM
|
+$50.2M |
| 5 |
ACAS
American Capital Ltd
ACAS
|
+$48.9M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$87.8M |
| 2 |
Chevron
CVX
|
+$86.7M |
| 3 |
Kohl's
KSS
|
+$53.6M |
| 4 |
General Mills
GIS
|
+$53.1M |
| 5 |
Elevance Health
ELV
|
+$48.9M |
Sector Composition
| 1 | Technology | 16.52% |
| 2 | Financials | 16.18% |
| 3 | Healthcare | 13.43% |
| 4 | Communication Services | 8.5% |
| 5 | Industrials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKZOY
801
DELISTED
AKZO NOBEL N V ADR
AKZOY
| $251K | ﹤0.01% |
+9,938
| New | +$251K |
|
802
Civitas Resources
CIVI
$3.11B
| $250K | ﹤0.01% |
91
+2
| +2% | +$5.5K |
|
803
Arbutus Biopharma
ABUS
$805M
| $249K | ﹤0.01% |
+14,263
| New | +$249K |
|
804
SPDR Gold Trust
GLD
$115B
| $249K | ﹤0.01% |
2,195
| – | – |
|
805
Ingredion
INGR
$8.24B
| $249K | ﹤0.01% |
3,204
-18,782
| -85% | -$1.46M |
|
806
TSMC
TSM
$1.28T
| $248K | ﹤0.01% |
+10,541
| New | +$248K |
|
807
Xcel Energy
XEL
$42.4B
| $247K | ﹤0.01% |
7,100
| – | – |
|
|
NFX
808
DELISTED
Newfield Exploration
NFX
| $245K | ﹤0.01% |
6,974
-931
| -12% | -$32.7K |
|
|
RENX
809
DELISTED
RELX N.V.
RENX
| $243K | ﹤0.01% |
+15,018
| New | +$243K |
|
810
Edwards Lifesciences
EW
$47.1B
| $237K | ﹤0.01% |
+9,972
| New | +$237K |
|
|
SIR
811
DELISTED
SELECT INCOME REIT
SIR
| $237K | ﹤0.01% |
21,587
-161,437
| -88% | -$1.77M |
|
812
Flushing Financial
FFIC
$457M
| $236K | ﹤0.01% |
11,772
-747
| -6% | -$15K |
|
813
Plains All American Pipeline
PAA
$12.1B
| $236K | ﹤0.01% |
+4,830
| New | +$236K |
|
814
Herbalife
HLF
$1.02B
| $235K | ﹤0.01% |
11,000
-56,262
| -84% | -$1.2M |
|
815
Freeport-McMoran
FCX
$67B
| $231K | ﹤0.01% |
12,203
+3,260
| +36% | +$61.7K |
|
816
Gaming and Leisure Properties
GLPI
$13.7B
| $229K | ﹤0.01% |
+6,200
| New | +$229K |
|
817
DexCom
DXCM
$30.6B
| $226K | ﹤0.01% |
+14,496
| New | +$226K |
|
818
United Bankshares
UBSI
$5.41B
| $225K | ﹤0.01% |
+5,999
| New | +$225K |
|
|
PX
819
DELISTED
Praxair Inc
PX
| $219K | ﹤0.01% |
1,815
-299
| -14% | -$36.1K |
|
820
FirstEnergy
FE
$25B
| $218K | ﹤0.01% |
6,221
-41,425
| -87% | -$1.45M |
|
821
Phillips 66
PSX
$52.6B
| $216K | ﹤0.01% |
+2,753
| New | +$216K |
|
822
Sarepta Therapeutics
SRPT
$1.84B
| $216K | ﹤0.01% |
16,276
-26,426
| -62% | -$351K |
|
823
Advance Auto Parts
AAP
$3.66B
| $212K | ﹤0.01% |
+1,415
| New | +$212K |
|
824
Leggett & Platt
LEG
$1.38B
| $210K | ﹤0.01% |
+4,559
| New | +$210K |
|
|
RPRX
825
DELISTED
Repros Therapeutics Inc.
RPRX
| $206K | ﹤0.01% |
+23,961
| New | +$206K |
|